{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T04:45:08Z","timestamp":1697258708591},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Gastroenterol Hepatol"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1038\/ncpgasthep0339","type":"journal-article","created":{"date-parts":[[2005,12,5]],"date-time":"2005-12-05T11:19:50Z","timestamp":1133781590000},"page":"587-594","source":"Crossref","is-referenced-by-count":11,"title":["Therapy Insight: pyoderma gangrenosum\u2014old disease, new management"],"prefix":"10.1038","volume":"2","author":[{"given":"Simon","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Cripps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek P","family":"Jewell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFncpgasthep0339_CR1","first-page":"655","volume":"22","author":"LA Brunsting","year":"1930","unstructured":"Brunsting LA et al. (1930) Pyoderma gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Dermatol 22: 655\u2013680","journal-title":"Arch Dermatol"},{"key":"BFncpgasthep0339_CR2","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1001\/jama.284.12.1546","volume":"284","author":"AP Hughes","year":"2000","unstructured":"Hughes AP et al. (2000) Clinical features and treatment of peristomal pyoderma gangrenosum. JAMA 284: 1546\u20131548","journal-title":"JAMA"},{"key":"BFncpgasthep0339_CR3","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1002\/bjs.1800780613","volume":"78","author":"MD Levitt","year":"1991","unstructured":"Levitt MD et al. (1991) Pyoderma gangrenosum in inflammatory bowel disease. Br J Surg 78: 676\u2013678","journal-title":"Br J Surg"},{"key":"BFncpgasthep0339_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1046\/j.1523-1747.1998.00311.x","volume":"111","author":"Y Adachi","year":"1998","unstructured":"Adachi Y et al. (1998) Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. J Invest Dermatol 111: 259\u2013268","journal-title":"J Invest Dermatol"},{"key":"BFncpgasthep0339_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1046\/j.1468-3083.2002.00387.x","volume":"16","author":"H Schofer","year":"2002","unstructured":"Schofer H and Baur S (2002) Successful treatment of postoperative pyoderma gangrenosum with cyclosporin. J Eur Acad Dermatol Venereol 16: 148\u2013151","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"BFncpgasthep0339_CR6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/S0190-9622(98)70020-9","volume":"39","author":"G Weichert","year":"1998","unstructured":"Weichert G and Sauder DN (1998) Efficacy of tacrolimus (FK 506) in idiopathic treatment-resistant pyoderma gangrenosum. J Am Acad Dermatol 39: 648\u2013650","journal-title":"J Am Acad Dermatol"},{"key":"BFncpgasthep0339_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00054725-200102000-00001","volume":"7","author":"S Friedman","year":"2001","unstructured":"Friedman S et al. (2001) Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease. Inflamm Bowel Dis 7: 1\u20137","journal-title":"Inflamm Bowel Dis"},{"key":"BFncpgasthep0339_CR8","first-page":"173","volume":"55","author":"FC Powell","year":"1985","unstructured":"Powell FC et al. (1985) Pyoderma gangrenosum: a review of 86 patients. Q J Med 55: 173\u2013186","journal-title":"Q J Med"},{"key":"BFncpgasthep0339_CR9","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0190-9622(96)90428-4","volume":"34","author":"FC Powell","year":"1996","unstructured":"Powell FC et al. (1996) Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 34: 395\u2013409","journal-title":"J Am Acad Dermatol"},{"key":"BFncpgasthep0339_CR10","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","volume":"96","author":"CN Bernstein","year":"2001","unstructured":"Bernstein CN et al. (2001) The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96: 1116\u20131122","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0339_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0140-6736(97)10187-8","volume":"351","author":"JP Callen","year":"1998","unstructured":"Callen JP (1998) Pyoderma gangrenosum. Lancet 351: 581\u2013585","journal-title":"Lancet"},{"key":"BFncpgasthep0339_CR12","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s11894-003-0042-6","volume":"5","author":"T Orchard","year":"2003","unstructured":"Orchard T (2003) Extraintestinal complications of inflammatory bowel disease. Curr Gastroenterol Rep 5: 512\u2013517","journal-title":"Curr Gastroenterol Rep"},{"key":"BFncpgasthep0339_CR13","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1046\/j.1365-2133.1997.20022083.x","volume":"137","author":"P von den Driesch","year":"1997","unstructured":"von den Driesch P (1997) Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol 137: 1000\u20131005","journal-title":"Br J Dermatol"},{"key":"BFncpgasthep0339_CR14","first-page":"432","volume":"72","author":"HH Sams","year":"2003","unstructured":"Sams HH et al. (2003) Crohn's disease of the penis masquerading as pyoderma gangrenosum: a case report and review of the literature. Cutis 72: 432\u2013437","journal-title":"Cutis"},{"key":"BFncpgasthep0339_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1001\/archderm.1986.01660150073019","volume":"122","author":"RA Snyder","year":"1986","unstructured":"Snyder RA (1986) Pyoderma gangrenosum involving the head and neck. Arch Dermatol 122: 295\u2013302","journal-title":"Arch Dermatol"},{"key":"BFncpgasthep0339_CR16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1440-0960.1995.tb00919.x","volume":"36","author":"JA Wayte","year":"1995","unstructured":"Wayte JA et al. (1995) Pyoderma gangrenosum, erythema elevatum diutinum and IgA monoclonal gammopathy. Australas J Dermatol 36: 21\u201323","journal-title":"Australas J Dermatol"},{"key":"BFncpgasthep0339_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1159\/000018360","volume":"200","author":"H Beele","year":"2000","unstructured":"Beele H et al. (2000) Pyoderma gangrenosum as an early revelator of acute leukaemia. Dermatology 200: 176\u2013178","journal-title":"Dermatology"},{"key":"BFncpgasthep0339_CR18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000018315","volume":"200","author":"U Bader","year":"2000","unstructured":"Bader U et al. (2000) Leg ulcers in patients with myeloproliferative disorders: disease- or treatment-related? Dermatology 200: 45\u201348","journal-title":"Dermatology"},{"key":"BFncpgasthep0339_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/j.1365-2230.1994.tb01186.x","volume":"19","author":"V Goulden","year":"1994","unstructured":"Goulden V et al. (1994) Pyoderma gangrenosum associated with paroxysmal nocturnal haemoglobinuria. Clin Exp Dermatol 19: 271\u2013273","journal-title":"Clin Exp Dermatol"},{"key":"BFncpgasthep0339_CR20","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/0002-9343(87)90170-7","volume":"82","author":"KT Kanel","year":"1987","unstructured":"Kanel KT et al. (1987) Pyoderma gangrenosum with myelofibrosis. Am J Med 82: 1031\u20131034","journal-title":"Am J Med"},{"issue":"Suppl 2","key":"BFncpgasthep0339_CR21","first-page":"A23","volume":"54","author":"TN Brooklyn","year":"2005","unstructured":"Brooklyn TN et al. (2005) Infliximab for the treatment of pyoderma gangrenosum: a randomised, double-blind placebo-controlled trial [abstract]. Gut 54 (Suppl 2): A23","journal-title":"Gut"},{"key":"BFncpgasthep0339_CR22","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1067\/mjd.2000.104515","volume":"42","author":"CC Lyon","year":"2000","unstructured":"Lyon CC et al. (2000) Parastomal pyoderma gangrenosum: clinical features and management. J Am Acad Dermatol 42: 992\u20131002","journal-title":"J Am Acad Dermatol"},{"key":"BFncpgasthep0339_CR23","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/00004836-198512000-00011","volume":"7","author":"F Goldstein","year":"1985","unstructured":"Goldstein F et al. (1985) Intralesional steroid therapy of pyoderma gangrenosum. J Clin Gastroenterol 7: 499\u2013501","journal-title":"J Clin Gastroenterol"},{"key":"BFncpgasthep0339_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/095466301750163518","volume":"12","author":"CC Lyon","year":"2001","unstructured":"Lyon CC et al. (2001) Topical tacrolimus in the management of peristomal pyoderma gangrenosum. J Dermatolog Treat 12: 13\u201317","journal-title":"J Dermatolog Treat"},{"key":"BFncpgasthep0339_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000065843","volume":"205","author":"J Wenzel","year":"2002","unstructured":"Wenzel J et al. (2002) Topical treatment of pyoderma gangrenosum. Dermatology 205: 221\u2013223","journal-title":"Dermatology"},{"key":"BFncpgasthep0339_CR26","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1365-2133.1981.tb08173.x","volume":"104","author":"SM Breathnach","year":"1981","unstructured":"Breathnach SM et al. (1981) Idiopathic pyoderma gangrenosum and impaired lymphocyte function: failure of azathioprine and corticosteroid therapy. Br J Dermatol 104: 567\u2013573","journal-title":"Br J Dermatol"},{"key":"BFncpgasthep0339_CR27","first-page":"326","volume":"57","author":"AD Teitel","year":"1996","unstructured":"Teitel AD (1996) Treatment of pyoderma gangrenosum with methotrexate. Cutis 57: 326\u2013328","journal-title":"Cutis"},{"key":"BFncpgasthep0339_CR28","first-page":"135","volume":"60","author":"JM Carp","year":"1997","unstructured":"Carp JM et al. (1997) Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease. Cutis 60: 135\u2013138","journal-title":"Cutis"},{"key":"BFncpgasthep0339_CR29","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.4065\/71.12.1182","volume":"71","author":"KK Lim","year":"1996","unstructured":"Lim KK et al. (1996) Cyclosporine in the treatment of dermatologic disease: an update. Mayo Clin Proc 71: 1182\u20131191","journal-title":"Mayo Clin Proc"},{"key":"BFncpgasthep0339_CR30","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1159\/000065860","volume":"205","author":"F Grange","year":"2002","unstructured":"Grange F et al. (2002) Corticosteroid-resistant pyoderma gangrenosum associated with Crohn's disease: rapid cure with infliximab. Dermatology 205: 278\u2013280","journal-title":"Dermatology"},{"key":"BFncpgasthep0339_CR31","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/j.1365-2133.2003.05760.x","volume":"150","author":"L Jenne","year":"2004","unstructured":"Jenne L et al. (2004) Successful treatment of therapy-resistant chronic vegetating pyoderma gangrenosum with infliximab (chimeric antitumour necrosis factor antibody). Br J Dermatol 150: 380\u2013382","journal-title":"Br J Dermatol"},{"key":"BFncpgasthep0339_CR32","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1046\/j.1365-2133.2003.05294.x","volume":"148","author":"D Mimouni","year":"2003","unstructured":"Mimouni D et al. (2003) Infliximab for peristomal pyoderma gangrenosum. Br J Dermatol 148: 813\u2013816","journal-title":"Br J Dermatol"},{"key":"BFncpgasthep0339_CR33","first-page":"988","volume":"81","author":"E Galun","year":"1986","unstructured":"Galun E et al. (1986) Pyoderma gangrenosum complicating ulcerative colitis: successful treatment with methylprednisolone pulse therapy and dapsone. Am J Gastroenterol 81: 988\u2013989","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0339_CR34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/j.1365-2230.1991.tb00291.x","volume":"16","author":"OE Obasi","year":"1991","unstructured":"Obasi OE (1991) Pyoderma gangrenosum and malignant pyoderma in Nigeria. Clin Exp Dermatol 16: 34\u201337","journal-title":"Clin Exp Dermatol"},{"key":"BFncpgasthep0339_CR35","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1365-2133.1990.tb06300.x","volume":"123","author":"S Kang","year":"1990","unstructured":"Kang S and Dover JS (1990) Successful treatment of eruptive pyoderma gangrenosum with intravenous vancomycin and mezlocillin. Br J Dermatol 123: 389\u2013393","journal-title":"Br J Dermatol"},{"key":"BFncpgasthep0339_CR36","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1346-8138.2003.tb00418.x","volume":"30","author":"T Kaneko","year":"2003","unstructured":"Kaneko T et al. (2003) Superficial granulomatous pyoderma: a case report of two Japanese patients and clinical comparison with foreign patients. J Dermatol 30: 472\u2013476","journal-title":"J Dermatol"},{"key":"BFncpgasthep0339_CR37","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1046\/j.1365-2133.1998.02087.x","volume":"138","author":"AM Farrell","year":"1998","unstructured":"Farrell AM et al. (1998) Pyoderma gangrenosum of the penis. Br J Dermatol 138: 337\u2013340","journal-title":"Br J Dermatol"},{"key":"BFncpgasthep0339_CR38","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/j.1346-8138.1994.tb03320.x","volume":"21","author":"ES Miralles","year":"1994","unstructured":"Miralles ES et al. (1994) Minocycline hydrochloride hyperpigmentation complicating treatment of pyoderma gangrenosum. J Dermatol 21: 965\u2013967","journal-title":"J Dermatol"},{"key":"BFncpgasthep0339_CR39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/00000441-200105000-00004","volume":"321","author":"M Moraes","year":"2001","unstructured":"Moraes M and Russo G (2001) Thalidomide and its dermatologic uses. Am J Med Sci 321: 321\u2013326","journal-title":"Am J Med Sci"},{"key":"BFncpgasthep0339_CR40","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1212\/01.WNL.0000037480.59194.85","volume":"59","author":"V Chaudhry","year":"2002","unstructured":"Chaudhry V et al. (2002) Thalidomide-induced neuropathy. Neurology 59: 1872\u20131875","journal-title":"Neurology"},{"key":"BFncpgasthep0339_CR41","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1111\/j.1572-0241.2003.07657.x","volume":"98","author":"T Ohmori","year":"2003","unstructured":"Ohmori T et al. (2003) Treatment of pyoderma gangrenosum associated with Crohn's disease. Am J Gastroenterol 98: 2101\u20132102","journal-title":"Am J Gastroenterol"},{"key":"BFncpgasthep0339_CR42","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1067\/mjd.2002.120597","volume":"47","author":"T Kanekura","year":"2002","unstructured":"Kanekura T et al. (2002) Granulocyte and monocyte adsorption apheresis for pyoderma gangrenosum. J Am Acad Dermatol 47: 320\u2013321","journal-title":"J Am Acad Dermatol"},{"key":"BFncpgasthep0339_CR43","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.clim.2003.07.001","volume":"109","author":"P Biswas","year":"2003","unstructured":"Biswas P et al. (2003) In vivo modulation of leukocyte trafficking receptor following therapeutic purging of myeloid cells: implications for treatment of HIV infection and other immune disorders. Clin Immunol 109: 355\u2013358","journal-title":"Clin Immunol"},{"key":"BFncpgasthep0339_CR44","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000079897","volume":"209","author":"GJ Kontochristopoulos","year":"2004","unstructured":"Kontochristopoulos GJ et al. (2004) Treatment of pyoderma gangrenosum with low-dose colchicine. Dermatology 209: 233\u2013236","journal-title":"Dermatology"},{"key":"BFncpgasthep0339_CR45","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/S0140-6736(05)79420-4","volume":"351","author":"P Rampal","year":"1998","unstructured":"Rampal P et al. (1998) Colchicine in pyoderma gangrenosum. Lancet 351: 1134\u20131135","journal-title":"Lancet"},{"key":"BFncpgasthep0339_CR46","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1365-2133.1997.tb02169.x","volume":"136","author":"S Bulvik","year":"1997","unstructured":"Bulvik S and Jacobs P (1997) Pyoderma gangrenosum in myelodysplasia responding to granulocyte\u2013macrophage colony stimulating factor (GM-CSF). Br J Dermatol 136: 637\u2013638","journal-title":"Br J Dermatol"},{"key":"BFncpgasthep0339_CR47","first-page":"517","volume":"104","author":"RJ Sanchez","year":"1995","unstructured":"Sanchez RJ et al. (1995) The treatment of cyclosporine A-resistant pyoderma gangrenosum with recombinant interferon alfa-2. Med Clin (Barc) 104: 517\u2013518","journal-title":"Med Clin (Barc)"},{"key":"BFncpgasthep0339_CR48","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1046\/j.1365-2230.1999.00424.x","volume":"24","author":"R Kaminska","year":"1999","unstructured":"Kaminska R et al. (1999) Plasmapheresis and cyclophosphamide as successful treatments for pyoderma gangrenosum. Clin Exp Dermatol 24: 81\u201385","journal-title":"Clin Exp Dermatol"},{"key":"BFncpgasthep0339_CR49","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1001\/archderm.140.12.1427","volume":"140","author":"NH Daniels","year":"2004","unstructured":"Daniels NH and Callen JP (2004) Mycophenolate mofetil is an effective treatment for peristomal pyoderma gangrenosum. Arch Dermatol 140: 1427\u20131429","journal-title":"Arch Dermatol"},{"key":"BFncpgasthep0339_CR50","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1080\/09546630410020154","volume":"15","author":"MR Lee","year":"2004","unstructured":"Lee MR and Cooper AJ (2004) Mycophenolate mofetil in pyoderma gangrenosum. J Dermatolog Treat 15: 303\u2013307","journal-title":"J Dermatolog Treat"},{"key":"BFncpgasthep0339_CR51","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jaad.2004.10.006","volume":"53","author":"J Reichrath","year":"2005","unstructured":"Reichrath J et al. (2005) Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 53: 273\u2013283","journal-title":"J Am Acad Dermatol"}],"container-title":["Nature Clinical Practice Gastroenterology & Hepatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0339.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0339","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/ncpgasthep0339.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T20:01:35Z","timestamp":1684440095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncpgasthep0339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["BFncpgasthep0339"],"URL":"https:\/\/doi.org\/10.1038\/ncpgasthep0339","relation":{},"ISSN":["1743-4378","1743-4386"],"issn-type":[{"value":"1743-4378","type":"print"},{"value":"1743-4386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}